Correlation between fasting insulin, AUC-insulin and HOMA-index in PCOS-patients

Authors:
  • DHD. Hadziomerovic
    D. Hadziomerovic
  • LWL. Wildt
    L. Wildt

Abstract
Objectives: A substantial number of hyperandrogenemic women exhibit hyperinsulinemia and insulin resistance. Those patients have an increased risk of developing a metabolic syndrome in a younger age. The early identification and treatment of metabolic syndrome are therefore of particular importance. In this study we examined whether the different methods for assessment of hyperinsulinemia in PCOS-women are equally effective and how they correlate with the symptoms predestining metabolic syndrome. Methods: 107 women with PCOS (Rotterdam criteria), were recruited in a clinical study. Fasting insulin and fasting glucose as well as insulin response to 75g oral glucose load were measured. We calculated the HOMA-index and AUC-insulin for each patient and analysed their correlation with the fasting insulin levels. Then we explored the correlation of body mass index (BMI), waist to hip ratio (WHR), serum testosterone (T), free testosterone (fT), SHBG, systolic (RRs) and diastolic (RRd) blood pressure, LDL and HDL with hyperinsulinemia in each method of assessment. Results: We found a significant correlation between fasting insulin and AUC-insulin levels (pConclusion: We conclude that the fasting insulin is at least as effective as HOMA and AUC-insulin for assessment of hyperinsulinemia in PCOS-patients, despite its simple evaluation. It also appeared to have a better predictive value, due to its significant correlation with the other symptoms, regarding the metabolic syndrome. The evaluation of fasting insulin should therefore be obligatory part of diagnosis for PCOS-patients.
Keywords